|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury显示文摘 | Mondello S Linnet A Buki A | 2012 | Neurosurgery2012，70，3： | 1 |
| 2 | Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling 显示文摘 | Linnet J M ller A Peterson E | 2011 | Addiction2011，106，2： | 1 |
| 3 | Clinical utility of serum lev- els of ubiquitin C-terminal hydrolase as a biomarker for severe trau- matic brain injury显示文摘 | Mondello S Linnet A Buki A | 2012 | Neurosurgery2012，70，3： | 1 |
| 4 | Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury显示文摘 | Mondello S Linnet A Buki A | 2012 | Neurosurgery2012，70，3： | 1 |
| 5 | Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury 显示文摘 | Mondello S Linnet A Buki A | 2012 | Neurosurgery2012，70，3： | 1 |
| 6 | An oxcarbazepinerelated fatality with an overview of 26 oxcarbazepine postmortem cases显示文摘 | Linnet K Steentoft A Simonsen KW | 2008 | Forensic Sci Int2008，177，23： | 1 |
| 7 | Blood concentrations of clon-azepam and 7-aminoclonazepam in forensic cases inDenmark for the period 2002-2007显示文摘 | Steentoft A Linnet K | 2009 | Forensic Sci Int2009，184，13： | 1 |
| 8 | Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury显示文摘 | Mondello S Linnet A Bulci A | 2012 | Neurosurgery2012，70，3： | 1 |
| 9 | P-glycoprotein interaction with fis- peridone and 9-OH-risperidone studied in vitro, in knock-ant mice and in drug-drug interaction experiments 显示文摘 | Ejsing TB Pederscn A Linnet K | 2005 | Hum Psychopharm Clin2005，20，7： | 1 |
| 10 | Detecting objects u- sing color and depth segmentation with Kinect sen- sor 显示文摘 | JOSE-J LINNET A LUIS J | 2012 | Procedia Technology2012，14，： | 1 |
| 11 | Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury 显示文摘 | Mondello S Linnet A Buki A | 2012 | Neurosurgery2012，70，3： | 1 |
| 12 | Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury显示文摘 | Mondello S Linnet A Buki A | 2012 | Neurosurgery2012，70，3： | 1 |
| 13 | Metabolic profiling of four synthetic stimulants,including the novel indanyl-cathinone 5-PPDi,after human hepatocyte incubation显示文摘Synthetic cathinones are new psychoactive substances that represent a health risk worldwide.For most of the 130 reported compounds,information about toxicology and/or metabolism is not available,which hampers their detection(and subsequent medical treatment)in intoxication cases.The principles of forensic analytical chemistry and the use of powerful analytical techniques are indispensable for stab-lishing the most appropriate biomarkers for these substances.Human metabolic fate of synthetic cathinones can be assessed by the analysis of urine and blood obtained from authentic consumers;however,this type of samples is limited and difficult to access.In this work,the metabolic behaviour of three synthetic cathinones(4-CEC,4-CPrC and 5-PPDi)and one amphetamine(3-FEA)has been evalu-ated by incubation with pooled human hepatocytes and metabolite identification has been performed by high-resolution mass spectrometry.This in vitro approach has previously shown its feasibility for obtaining excretory human metabolites.4-CEC and 3-FEA were not metabolised,and for 4-CPrC only two minor metabolites were obtained.On the contrary,for the recently reported 5-PPDi,twelve phase I metabolites were elucidated.Up to our knowledge,this is the first metabolic study of an indanyl-cathinone.Data reported in this paper will allow the detection of these synthetic stimulants in intoxi-cation cases,and will facilitate future research on the metabolic behaviour of other indanyl-based cathinones. | David Fabregat-Safont Marie Mardal Juan V.Sancho Félix Hernández Kristian Linnet María Ibánez | 2020 | Journal of Pharmaceutical Analysis2020，10，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员